RCAG
WST icon

Rehmann Capital Advisory Group’s West Pharmaceutical WST Stock Holding History

Rehmann Capital Advisory Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-758
Closed -$248K – 629
2024
Q4 		$248K Sell
758
-17
-2% -$5.35K 0.02% 517
2024
Q3 		$229K Sell
775
-26
-3% -$7.96K 0.02% 541
2024
Q2 		$264K Buy
801
+165
+26% +$58.3K 0.02% 484
2024
Q1 		$252K Sell
636
-12
-2% -$4.44K 0.02% 498
2023
Q4 		$228K Hold
648
– – 0.02% 504
2023
Q3 		$243K Sell
648
-89
-12% -$34.4K 0.02% 448
2023
Q2 		$282K Sell
737
-20
-3% -$7.14K 0.03% 437
2023
Q1 		$263K Buy
+757
New +$221K 0.02% 450
2022
Q4 		– Sell
-816
Closed -$201K – 582
2022
Q3 		$201K Buy
816
+26
+3% +$7.92K 0.02% 490
2022
Q2 		$239K Sell
790
-22
-3% -$7.16K 0.03% 426
2022
Q1 		$334K Sell
812
-16
-2% -$6.26K 0.03% 386
2021
Q4 		$389K Sell
828
-8
-1% -$3.44K 0.04% 378
2021
Q3 		$355K Sell
836
-15
-2% -$6.32K 0.03% 399
2021
Q2 		$309K Buy
851
+33
+4% +$10.9K 0.03% 424
2021
Q1 		$231K Sell
818
-6
-0.7% -$1.72K 0.02% 470
2020
Q4 		$234K Buy
824
+60
+8% +$16.8K 0.03% 436
2020
Q3 		$210K Buy
+764
New +$202K 0.03% 396
2019
Q3 		$92K Hold
649
– – 0.01% 469
2019
Q2 		$81.2K Hold
649
– – 0.01% 680
2019
Q1 		$71.5K Buy
649
+14
+2% +$1.46K 0.01% 691
2018
Q4 		$62.2K Hold
635
– – 0.01% 523
2018
Q3 		$78.4K Buy
635
+32
+5% +$3.59K 0.01% 657
2018
Q2 		$59.9K Sell
603
-34
-5% -$3.13K 0.01% 715
2018
Q1 		$56K Buy
+637
New +$59.6K 0.01% 724

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Rehmann Capital Advisory Group's WST Position: Q1 2025 in Review

Rehmann Capital Advisory Group sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 758 shares — an estimated $248K sold.

Rehmann Capital Advisory Group first reported a position in WST in Q1 2018 and held it in 24 quarters. The position peaked at $389K in Q4 2021. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Rehmann Capital Advisory Group reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 758 West Pharmaceutical shares in Q1 2025, an estimated $248K.
  • Rehmann Capital Advisory Group first reported a position in West Pharmaceutical in Q1 2018 and held it in 24 quarters.
  • Rehmann Capital Advisory Group's West Pharmaceutical position peaked at $389K in Q4 2021.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2025, filed 30 Apr 2025.